Annual Report for the Financial Year 2024-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies Limited has filed its Annual Report for FY 2024-25 with BSE, along with the notice for its 15th Annual General Meeting to be held on Wednesday, 17th September 2025 at 4:00 PM via Video Conferencing. The AGM agenda includes adoption of audited financial statements, re-appointment of Managing Director Mr. Bhumishth Patel (retiring by rotation), and appointment of M/s. H Thakkar & Co. LLP as statutory auditor for a 5-year term until the 19th AGM in 2029. The company is also seeking shareholder approval for material related party transactions of up to Rs. 50 crore each with eight related parties: Poshan Nutriwell Pvt Ltd, Solaris Agritech Pvt Ltd, Recurso Wellness Pvt Ltd, EL Faro Ventures Ltd, Vogue Lifestyle Pvt Ltd, Patron Exim Ltd, Solis Inventions Pvt Ltd, and Atlantis Exim. E-voting will run from 14th to 16th September 2025, with the cut-off date set as 10th September 2025.
Shareholders should review the Annual Report and exercise their voting rights on key resolutions, including the significant related party transaction approvals totalling up to Rs. 400 crore across eight related parties. The large RPT proposals are worth monitoring closely for governance and conflict-of-interest considerations.